CHG (Stock Code: 673) Updates on Auditor’s Disclaimer of Opinion for FY2025

Bulletin Express

01/23

China Health Group Limited (CHG, Stock Code: 673) issued an update related to the auditor’s disclaimer of opinion on the Company’s consolidated financial statements for the year ended 31 March 2025. The Company indicated that it continues to address liquidity concerns and is implementing measures to resolve the going concern issue.

CHG has completed several financing initiatives, including subscriptions and a rights issue, which provided aggregate net proceeds of approximately HK$80.9 million in October 2025. The Board is also negotiating to renew the Group’s bank borrowing of approximately HK$5.4 million as at 31 March 2025 and targets finalizing these negotiations by the end of the first quarter of 2026.

The Company plans to provide updates every three months from 23 January 2026 until the auditor’s disclaimer is resolved. Shareholders and investors are advised to remain cautious when dealing in the Company’s securities.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1115472051"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1115472051\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1115472051?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-23 20:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115472051","market":"us","top_or_hot":-1,"title":"CHG (Stock Code: 673) Updates on Auditor’s Disclaimer of Opinion for FY2025","media":"Bulletin Express","content":"<p>China Health Group Limited (CHG, Stock Code: 673) issued an update related to the auditor’s disclaimer of opinion on the Company’s consolidated financial statements for the year ended 31 March 2025. The Company indicated that it continues to address liquidity concerns and is implementing measures to resolve the going concern issue.</p>\n<p>CHG has completed several financing initiatives, including subscriptions and a rights issue, which provided aggregate net proceeds of approximately HK$80.9 million in October 2025. The Board is also negotiating to renew the Group’s bank borrowing of approximately HK$5.4 million as at 31 March 2025 and targets finalizing these negotiations by the end of the first quarter of 2026.</p>\n<p>The Company plans to provide updates every three months from 23 January 2026 until the auditor’s disclaimer is resolved. Shareholders and investors are advised to remain cautious when dealing in the Company’s securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CHG (Stock Code: 673) Updates on Auditor’s Disclaimer of Opinion for FY2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCHG (Stock Code: 673) Updates on Auditor’s Disclaimer of Opinion for FY2025\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-01-23 20:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>China Health Group Limited (CHG, Stock Code: 673) issued an update related to the auditor’s disclaimer of opinion on the Company’s consolidated financial statements for the year ended 31 March 2025. The Company indicated that it continues to address liquidity concerns and is implementing measures to resolve the going concern issue.</p>\n<p>CHG has completed several financing initiatives, including subscriptions and a rights issue, which provided aggregate net proceeds of approximately HK$80.9 million in October 2025. The Board is also negotiating to renew the Group’s bank borrowing of approximately HK$5.4 million as at 31 March 2025 and targets finalizing these negotiations by the end of the first quarter of 2026.</p>\n<p>The Company plans to provide updates every three months from 23 January 2026 until the auditor’s disclaimer is resolved. Shareholders and investors are advised to remain cautious when dealing in the Company’s securities.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00673","symbol_name":"中國衞生集團","start_time":0,"source_url":"","article_id":"1115472051","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115472051","pubTimestamp":1769171046,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Health Group Limited (CHG, Stock Code: 673) issued an update related to the auditor’s disclaimer of opinion on the Company’s consolidated financial statements for the year ended 31 March 2025....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00673":"中国卫生集团"},"translate_title":"CHG（股份代号：673）有关二零二五财政年度核数师不发表意见的更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00673":1},"content_text":"China Health Group Limited (CHG, Stock Code: 673) issued an update related to the auditor’s disclaimer of opinion on the Company’s consolidated financial statements for the year ended 31 March 2025. The Company indicated that it continues to address liquidity concerns and is implementing measures to resolve the going concern issue.\nCHG has completed several financing initiatives, including subscriptions and a rights issue, which provided aggregate net proceeds of approximately HK$80.9 million in October 2025. The Board is also negotiating to renew the Group’s bank borrowing of approximately HK$5.4 million as at 31 March 2025 and targets finalizing these negotiations by the end of the first quarter of 2026.\nThe Company plans to provide updates every three months from 23 January 2026 until the auditor’s disclaimer is resolved. Shareholders and investors are advised to remain cautious when dealing in the Company’s securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}